Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Xu Liu et al.|The Lancet|2021Cited by 234
Novel immunological and nutritional-based prognostic index for gastric cancerKaiyu Sun, Yulong He, Chuangqi Chen et al.|World Journal of Gastroenterology|2015Cited by 101
The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapyHui Wu, Haiping Jiang|BMC Cancer|2025Cited by 0